As Fabio Gratton, chief innovation officer of the healthcare marketing agency Ignite Health of Irvine ... Whereas some sites are industry sponsored—BioMarin, in Novato, California, for example ...

BioMarin's has signed the first contract with an insurer in Germany for Roctavian, its recently approved gene therapy for haemophilia A, as it tests out its outcomes-based agreement (OBA ...

BioMarin Pharmaceutical has made a couple of appointments aimed at boosting its pipeline, both internally and externally, with C-suite appointments in charge of R&D and business development.

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

After hours: March 21 at 7:51:47 PM EDT Loading Chart for BMRN ...

View BioMarin Pharmaceutical Inc. (BMRN) current and estimated P/E ratio data provided by Seeking Alpha.